Literature DB >> 11169013

DNA damage of lymphocytes in experimental chronic renal failure: beneficial effects of losartan.

Z Krivosíková1, M Dusinská, V Spustová, K Sebeková, P Blazícek, A Heidland, R Dzúrik.   

Abstract

BACKGROUND: Kidney diseases are associated with the accumulation of various uremic toxins increasing the oxygen free radical (OFR) activity with a number of serious consequences. One of them could be the impairment of DNA stability with the increased formation of DNA breaks.
METHODS: The study was performed in 4/6 kidney ablation rat nephropathy lasting for three months. The results of sham-operated (Sham), remnant kidney (Nx), and Nx treated by losartan (NxL) were compared.
RESULTS: Nx significantly increased blood pressure, plasma creatinine, urea, hippurate, malondialdehyde (MDA), lipofuscin (LF), and the number of DNA breaks of lymphocytes. Losartan decreased the rise of blood pressure and inhibited the rise of creatinine plasma concentration but not of other variables, while it markedly inhibited the number of DNA breaks (Sham 15.9 +/- 1.1, Nx 54.5 +/- 1.7, P < 0.001; Nx/Sham, NxL 23.3 +/- 2.6 P < 0.001, NxL/Sham and P < 0.001 NxL/Nx).
CONCLUSIONS: The 4/6 kidney ablation nephropathy increases the susceptibility of lymphocyte DNA to breaks, and losartan inhibits the number of breaks by a mechanism independent on glomerular filtration, accumulation of MDA or LF (markers of oxidative stress), and hippurate (marker of the accumulation of middle molecular substances). An independent mechanism, probably the interference with proliferation, is suggested.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11169013     DOI: 10.1046/j.1523-1755.2001.59780212.x

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN: 0098-6577            Impact factor:   10.545


  4 in total

1.  Prevention of DNA damage in renal transplantation by losartan and enalapril: the role of renin-angiotensin system polymorphisms.

Authors:  Amir Ghorbanihaghjo; Pegah Veisi; Hassan Argani; Mohammad Aghaeishahsavari; Masood Noroozianavval; Nadereh Rashtchizadeh; Mehran Mesgari; Javid Safa; Hosain Babaei
Journal:  Clin Exp Nephrol       Date:  2008-01-05       Impact factor: 2.801

2.  Intravenous iron exacerbates oxidative DNA damage in peripheral blood lymphocytes in chronic hemodialysis patients.

Authors:  Ko-Lin Kuo; Szu-Chun Hung; Yau-Huei Wei; Der-Cherng Tarng
Journal:  J Am Soc Nephrol       Date:  2008-05-21       Impact factor: 10.121

3.  An ACE inhibitor reduces Th2 cytokines and TGF-beta1 and TGF-beta2 isoforms in murine lupus nephritis.

Authors:  Deijanira Alves De Albuquerque; Vijay Saxena; David E Adams; Gregory P Boivin; Hermine I Brunner; David P Witte; Ram Raj Singh
Journal:  Kidney Int       Date:  2004-03       Impact factor: 10.612

Review 4.  Oxidative stress and nucleic acid oxidation in patients with chronic kidney disease.

Authors:  Chih-Chien Sung; Yu-Chuan Hsu; Chun-Chi Chen; Yuh-Feng Lin; Chia-Chao Wu
Journal:  Oxid Med Cell Longev       Date:  2013-08-24       Impact factor: 6.543

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.